CCNE Stock Analysis: CNB Financial | NASDAQ
Banks - Regional | NASDAQ, USA | Market Cap: 1.056m USD | 12M Return: 45.5% | US1261281075 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 5.04M
EPS Trend: 85.7%
Qual. Beats: 0
Rev. Trend: 97.5%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
CNB Financial Corporation is a Pennsylvania-based bank holding company that operates CNB Bank, providing a full suite of banking and financial services to individual, business, governmental, and institutional customers. Founded in 1865 and headquartered in Clearfield, Pennsylvania, the company accepts checking, savings, and time deposit accounts and originates real estate, commercial, industrial, residential, and consumer loans.
In addition to traditional banking, CNB offers private banking, wealth and asset management, trust and estate administration, retirement and employee benefit plan services, and sells nonproprietary annuities and insurance products. The company also maintains a securities investment portfolio and engages in consumer and small-balance lending, including auto- and equipment-secured loans and a consumer discount loan and finance business. As a small-cap regional bank listed on NASDAQ under the ticker CCNE, CNB operates within the U.S. community banking sector, which typically generates revenue from net interest income (the spread between loan yields and deposit costs) supplemented by fee-based services such as wealth management and insurance commissions.
- Net interest margin expansion on Fed rate hold
- Loan growth drives earnings across Pennsylvania and New York footprint
- Wealth and asset management fees scale as AUM grows
- Capital return accelerates via dividends and active share repurchases
- Credit quality remains stable with low commercial real estate charge-offs
| Net Income: 117.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA 0.38 > 1.0 |
| NWC/Revenue: -1.27k% < 20% (prev -1.59k%; Δ 317.2% < -1%) |
| CFO/TA 0.01 > 3% & CFO 87.4m > Net Income 117.0m |
| Net Debt (-937.4m) to EBITDA (148.3m): -6.32 < 3 |
| Current Ratio: 0.16 > 1.5 & < 3 |
| Outstanding Shares: last quarter (29.5m) vs 12m ago 27.99% < -2% |
| Gross Margin: 69.09% > 18% (prev 56.59%; Δ 12.50% > 0.5%) |
| Asset Turnover: 5.74% > 50% (prev 4.77%; Δ 0.97% > 0%) |
| Interest Coverage Ratio: 0.84 > 6 (EBIT TTM 133.3m / Interest Expense TTM 158.0m) |
| A: -0.73 (Total Current Assets 1.20b - Total Current Liabilities 7.29b) / Total Assets 8.39b |
| B: 0.06 (Retained Earnings 488.2m / Total Assets 8.39b) |
| C: 0.02 (EBIT TTM 133.3m / Avg Total Assets 8.32b) |
| D: 0.12 (Book Value of Equity 912.5m / Total Liabilities 7.47b) |
| Altman-Z'' = -4.34 = D |
| DSRI: 0.84 (Receivables 6.55b/6.40b, Revenue 478.0m/393.8m) |
| GMI: 0.82 (GM 56.59% / 69.09%) |
| AQI: 0.95 (AQ_t 0.84 / AQ_t-1 0.88) |
| SGI: 1.21 (Revenue 478.0m / 393.8m) |
| TATA: 0.00 (NI 117.0m - CFO 87.4m) / TA 8.39b) |
| Beneish M = -3.19 (Cap -4..+1) = AA |
As of November 20, 2026, the stock is trading at USD 34.07 with a total of 199,091 shares traded. Over the past week, the price has changed by -4.41%, over one month by +0.24%, over three months by +1.25% and over the past year by +45.46%.
Current recommended Stop Loss: 32.40 (which is 4.9% or 1.9 ATR below the current price).
CNB Financial has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy CCNE.
- StrongBuy: 2
- Buy: 2
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 38.5 | 13% |
P/E Trailing = 9.0228
P/E Forward = 10.1215
P/S = 3.1231
P/B = 1.2422
P/EG = 1.0613
Revenue TTM = 478.0m USD
EBIT TTM = 133.3m USD
EBITDA TTM = 148.3m USD
Long Term Debt = 55.6m USD (from longTermDebt, last quarter)
Short Term Debt = 164.0m USD (from shortTermDebt, last quarter)
Debt = 263.0m USD (from shortLongTermDebtTotal, last quarter) + Leases 43.4m
Net Debt = -937.4m USD (calculated: Debt 263.0m - CCE 1.20b)
Enterprise Value = 118.2m USD (1.06b + Debt 263.0m - CCE 1.20b)
Interest Coverage Ratio = 0.84 (Ebit TTM 133.3m / Interest Expense TTM 158.0m)
EV/FCF = 1.40x (Enterprise Value 118.2m / FCF TTM 84.4m)
FCF Yield = 71.45% (FCF TTM 84.4m / Enterprise Value 118.2m)
FCF Margin = 17.66% (FCF TTM 84.4m / Revenue TTM 478.0m)
Net Margin = 24.49% (Net Income TTM 117.0m / Revenue TTM 478.0m)
Gross Margin = 69.09% ((Revenue TTM 478.0m - Cost of Revenue TTM 147.7m) / Revenue TTM)
Gross Margin QoQ = 66.67% (prev 67.64%)
Tobins Q-Ratio = 0.01 (Enterprise Value 118.2m / Total Assets 8.39b)
Interest Expense / Debt = 60.07% (Interest Expense 158.0m / Debt 263.0m)
Taxrate = 18.32% (26.3m / 143.3m)
NOPAT = 108.9m (EBIT 133.3m * (1 - 18.32%))
Current Ratio = 0.16 (Total Current Assets 1.20b / Total Current Liabilities 7.29b)
Debt / Equity = 0.29 (Debt 263.0m / totalStockholderEquity, last quarter 912.5m)
Debt / EBITDA = -6.32 (Net Debt -937.4m / EBITDA 148.3m)
Debt / FCF = -11.10 (Net Debt -937.4m / FCF TTM 84.4m)
Total Stockholder Equity = 895.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.41% (Net Income 117.0m / Total Assets 8.39b)
RoE = 13.07% (Net Income TTM 117.0m / Total Stockholder Equity 895.8m)
RoCE = 14.01% (EBIT 133.3m / Capital Employed (Equity 895.8m + L.T.Debt 55.6m))
RoIC = 8.81% (NOPAT 108.9m / Invested Capital 1.24b)
WACC = 5.81% (E(1.06b)/V(1.32b) * Re(7.26%) + (debt cost/tax rate unavailable))
Discount Rate = 7.26% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 89.16 | Cagr: 16.63%
[DCF] Terminal Value 77.97% ; FCFF base≈71.3m ; Y1≈81.7m ; Y5≈120.2m
[DCF] Fair Price = 92.74 (EV 1.81b - Net Debt -937.4m = Equity 2.75b / Shares 29.6m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 85.70 | EPS CAGR: 16.21% | SUE: 0.84 | # QB: 0
Revenue Correlation: 97.54 | Revenue CAGR: 15.17% | SUE: 0.67 | # QB: 0
EPS current Quarter (2027-03-31): EPS=0.87 | Chg30d=-0.77% | Revisions=+29% | Analysts=6
EPS current Year (2026-12-31): EPS=3.58 | Chg30d=+0.75% | Revisions=+22% | GrowthEPS=+21.2% | GrowthRev=+42.8%
EPS next Year (2027-12-31): EPS=3.71 | Chg30d=-0.54% | Revisions=+38% | GrowthEPS=+3.8% | GrowthRev=+5.5%
[Analyst] Revisions Ratio: +39% (up=11, down=4)